Navigation Links
Soligenix Submits NIAID Contract Proposal for Development of a Thermostable Ricin Vaccine
Date:10/31/2013

AID.  In addition, our organizational structure and experience allows Soligenix to be a valuable strategic partner for NIAID, as well as with the other agencies we currently work with."

The submission of our proposal is non-binding and does not guarantee the award of a NIAID contract.  The contract award will require a favorable technical, scientific and business review by NIAID followed by negotiation of fair and reasonable contract terms.

About RiVax™

RiVax™ is Soligenix's proprietary recombinant subunit vaccine developed to protect against exposure to ricin toxin. With RiVax™, Soligenix is a world leader in the area of ricin toxin vaccine research.

RiVax™ contains a genetically altered version of ricin A chain containing two mutations that inactivate the inherent toxicity of the ricin molecule. The Phase 1A clinical trial was conducted with a formulation of RiVax™ that did not contain an adjuvant. That trial revealed dose dependent seroconversion as well as lack of toxicity of the molecule when administered intramuscularly to human volunteers. The adjuvant-free formulation of  RiVax™ induced toxin neutralizing antibodies that lasted up to 127 days after the third vaccination in several individuals.  To increase the longevity and magnitude of toxin neutralizing antibodies, RiVax™ was formulated with an adjuvant of aluminum salts (known colloquially as Alum) for the Phase 1B clinical trial.  Alum is an adjuvant that is used in many human vaccines, including most vaccines used in infants. In preclinical animal studies, the Alum formulation of RiVax™ induced higher titers and longer lasting antibodies than the adjuvant-free vaccine. 

The development of RiVax™ has been sponsored through a series of overlapping grants from both the NIAID and FDA, which were granted to Soligenix and to UTSW where the vaccine originated. To date, Soligenix and UTSW ha
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
2. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
3. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
4. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
5. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
6. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
7. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
8. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
9. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
10. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
11. Soligenix to Present at World Vaccine Congress & Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Research and Markets ... of the "North American Computerized Physician ... Physician Order Entry, Standalone Computerized Physician Order ... Forecast to 2019 " report to ... , The North American computerized ...
(Date:5/26/2015)... May 26, 2015  PAREXEL International Corporation (NASDAQ: ... at the Goldman Sachs Healthcare Conference in Palos Verdes, ... Executive Officer, will be making a presentation on PAREXEL ... Tuesday, June 9, 2015. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
(Date:5/26/2015)... today announced the launch of its initial public offering ... represent 25.6% of its outstanding common stock following its ... in connection with the offering. The initial public offering ... $17 per share. The underwriters for the offering will ... an additional 937,500 shares of EndoChoice common stock. EndoChoice ...
Breaking Medicine Technology:North American Computerized Physician Order Entry Market 2015-2019 2PAREXEL International To Present At Goldman Sachs Healthcare Conference 2EndoChoice Announces Launch of Its Initial Public Offering 2
... Roper Industries, Inc. (NYSE: ROP ) ... discuss first quarter 2011 results to 8:00 AM ET ... originally scheduled.  The call can be accessed via webcast ... using confirmation code 5338709.  Webcast information and conference call ...
... CINCINNATI, April 11, 2011 CarePoint ... Premier Infusion (Premier). Premier provides home infusion pharmacy ... related nursing services in the Atlanta, Georgia area. ... operations while CarePoint also continues to grow its ...
Cached Medicine Technology:CarePoint Partners Expands Texas Presence and Opens Georgia Market With Acquisition of Premier Infusion 2
(Date:5/26/2015)... May 26, 2015 Scientists at the ... way to help advanced mesothelioma patients benefit from immunotherapy; ... posted an article on the new research. Click ... the departments of thoracic surgery and pulmonology theorized that, ... an immune system attack, immunotherapy drugs might work better ...
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 ProTrailer ... for Final Cut Pro X . This ... to simple and elegantly styled text. , ProTrailer ... seconds. , ProTrailer Network can easily complement any form ... desired and within seconds can make professional looking openers. ...
(Date:5/26/2015)... Learning ZoneXpress is excited to announce a ... . These cards have been specifically designed for WIC, ... text, these new educational resources are extremely useful ... tips and suggestions to clients and provide an individualized ... MyPlate: Eat for a Healthy Baby Pregnancy Education Cards, ...
(Date:5/26/2015)... 2015 DENVER (May 26, 2015) – ... it is also experiencing many of the growing pains ... counterparts, one major issue that cannabis companies now have ... of paper and plastic that marijuana growers, dispensaries and ... waste we see the opportunity to enhance our environment ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 The European imaging ... suggests over 45% of healthcare providers plan to make purchases. ... latest industry report. Data collected from these participants show that ... pathology takes a back seat. , “Many imaging IT ... year,” said peer60 CEO Jeremy Bikman. “This report details the ...
Breaking Medicine News(10 mins):Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 3Health News:peer60 report: European Healthcare IT Imaging Purchases: 2015 2
... LONG BEACH, Calif., Nov. 6 A class action,lawsuit ... Court,against S&F Management Company, Inc.; S&F Management Company, LLC; ... facilities,around the state [See list by city at end ... his Attorney in Fact, Virginia Boone, on his behalf,and ...
... Helps Organizations Rapidly Identify High-Risk Cases, ... Underwriting, BIRMINGHAM, Ala., Nov. 6 ... and DST Health Solutions announced that 16,organizations ... that helps organizations rapidly identify at-risk patients ...
... hospital discharge rates in Raleigh and 6 ... ... has,participated in a seven-city study on the impact of new CPR techniques, ... 2005 CPR guidelines, according to the study authors in a,presentation at the ...
... Inc.,(NYSE: CSA ), a real estate investment trust ... profession, including medical,offices, ambulatory surgery and diagnostic centers, today ... Third Quarter 2007 Results Cogdell Spencer Inc. ... unit of $0.30 and net loss per share of ...
... Tezosentan didn,t change outcomes for patients with sudden, life-threatening ... -- An experimental kind of medication has failed ... heart failure, a new trial finds. , The drug, ... of major cardiovascular events, or cut their risk ...
... ... Encourages Consistent Exercise for Individuals and ... Families -, PITTSBURGH, Nov. ... maintaining a healthy,lifestyle. The Amerathon Club has introduced a new online and interactive,total wellness ...
Cached Medicine News:Health News:Class Action Lawsuit Filed Against 15 California Nursing Homes 2Health News:Class Action Lawsuit Filed Against 15 California Nursing Homes 3Health News:Sixteen Organizations Implement ACG Rx-PM Predictive Modeling from Johns Hopkins University, DST Health Solutions 2Health News:Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 2Health News:Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 3Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 2Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 3Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 4Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 5Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 6Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 7Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 8Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 9Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 10Health News:Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results 11Health News:Experimental Drug Fails Against Heart Failure 2Health News:Experimental Drug Fails Against Heart Failure 3Health News:Innovative Amerathon Club Website 'Virtual' Journey to Good Health 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: